MCID: LYM017
MIFTS: 63

Lyme Disease malady

Categories: Rare diseases, Infectious diseases, Neuronal diseases, Skin diseases

Aliases & Classifications for Lyme Disease

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 38MedlinePlus, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Lyme Disease:

Name: Lyme Disease 11 48 54 50 38 2 39 13 68
Lyme Neuroborreliosis 11 50 39 68
Lyme Borreliosis 11 48 54 13
Neuroborreliosis 11 68
Borreliosis 48 50
 
Neurological Lyme Disease 11
Bannworth's Syndrome 11
Borrelia Infections 68
Bannwarth Syndrome 11

Characteristics:

Orphanet epidemiological data:

54
lyme disease:
Inheritance: Not applicable; Prevalence: >1/1000 (Europe),1-5/10000 (France); Age of onset: All ages

Classifications:



External Ids:

Disease Ontology11 DOID:11729
ICD1030 A69.2, A69.20
ICD9CM32 088.81
NCIt45 C45161
Orphanet54 ORPHA91546
MESH via Orphanet40 D008193
UMLS via Orphanet69 C0024198
ICD10 via Orphanet31 A69.2

Summaries for Lyme Disease

About this section
MedlinePlus:38 Lyme disease is a bacterial infection you get from the bite of an infected tick. the first symptom is usually a red rash, which may look like a bull's eye. but not all people with lyme disease have a rash. as the infection spreads to other parts of the body, you may have a fever a headache body aches a stiff neck fatigue lyme disease can be hard to diagnose because many of its symptoms are like those of the flu and other diseases. and you may not have noticed a tick bite. your health care provider will look at your symptoms and medical history to figure out whether you have lyme disease. lab tests may not always give a clear answer until you have been infected for at least a few weeks. antibiotics can cure most cases of lyme disease. the sooner treatment begins, the quicker and more complete the recovery. after treatment, some patients may still have muscle or joint aches and nervous system symptoms. this is called post-treatment lyme disease syndrome (ptlds). long-term antibiotics have not been shown to help with ptlds. however, there are ways to help with the symptoms of ptlds, and most patients do get better with time. nih: national institute of allergy and infectious diseases

MalaCards based summary: Lyme Disease, also known as lyme neuroborreliosis, is related to spotted fever and neuropathy, and has symptoms including fever, pruritus and Array. An important gene associated with Lyme Disease is YBX3 (Y-Box Binding Protein 3), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and LDL Oxidation in Atherogenesis. Affiliated tissues include heart, testes and skin, and related mouse phenotypes are cardiovascular system and renal/urinary system.

NIH Rare Diseases:48 Lyme disease is the most common tickborne infectious disease in the united states. early signs and symptoms of the condition include fever, chills, muscle pain, headache, and joint pain. as the condition progresses, affected people may experience heart problems, bell's palsy, arthritis, abnormal muscle movement, speech problems and cognitive (thinking) abnormalities. please visit the center for disease control and prevention's web site for a more comprehensive list of symptoms. lyme disease is caused by the bacterium borrelia burgdorferi, which is transmitted to humans through the bite of infected blacklegged ticks. certain features of the condition, including whether or not an affected person will develop medication-resistant chronic arthritis, is thought to be influenced by genetic factors (certain human leukocyte antigen genes). treatment generally includes antibiotics to address the bacterial infection and other medications (i.e. pain medications) to relieve symptoms. last updated: 10/6/2015

CDC:2 Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. Lyme disease is diagnosed based on symptoms, physical findings (e.g., rash), and the possibility of exposure to infected ticks.  Laboratory testing is helpful if used correctly and performed with validated methods. Most cases of Lyme disease can be treated successfully with a few weeks of antibiotics. Steps to prevent Lyme disease include using insect repellent, removing ticks promptly, applying pesticides, and reducing tick habitat. The ticks that transmit Lyme disease can occasionally transmit other tickborne diseases as well.

Disease Ontology:11 A primary bacterial infectious disease that results in infection, has material basis in Borrelia burgdorferi, which is transmitted by blacklegged tick (Ixodes scapularis) or transmitted by western blacklegged tick (Ixodes pacificus). The infection has symptom fever, has symptom headache, has symptom fatigue, and has symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system.

Wikipedia:71 Lyme disease, also known as Lyme borreliosis, is an infectious disease caused by bacteria of the... more...

Related Diseases for Lyme Disease

About this section

Diseases related to Lyme Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 313)
idRelated DiseaseScoreTop Affiliating Genes
1spotted fever30.1CD40LG, TLR2, TNF
2neuropathy29.9IL1B, IL6, TNF
3choroiditis29.6IL1B, IL6, TNF
4oculomotor nerve paralysis29.5IL1B, IL6
5central nervous system lymphoma29.3IL1B, IL6, TNF
6tuberculosis28.9CD40LG, IL17A, IL1B, IL6, TNF
7rheumatoid arthritis28.3CD40LG, HSPD1, IL17A, IL1B, IL6, TLR2
8lyme disease - neurological complications12.2
9babesiosis11.1
10human granulocytic anaplasmosis11.1
11powassan encephalitis11.1
12tick infestation11.1
13pars planitis10.7
14intermediate uveitis10.7
15atrophoderma of pierini and pasini10.7
16autoimmune inner ear disease10.7
17idiopathic hypertrophic pachymeningitis10.7
18lymphocytic infiltrate of jessner10.7
19pseudopelade of brocq10.7
20monosomy 9q22.310.2C3, MMP9
21macular degeneration, age-related, 410.2CFH, CFHR1
22premature menopause10.2HSPD1, IL6, TLR2
23lateral cystocele10.2CD40LG, IL6, TLR1
24vps11-related autosomal recessive hypomyelinating leukodystrophy10.2IL6, TNF
25usher syndrome, type 2a10.2IL6, TLR1, TLR2
26intussusception10.2IL1B, TNF
27immune-complex glomerulonephritis10.2C3, CFH, IL6
28ehrlichiosis10.2
29relapsing fever10.2
30common peroneal nerve lesion10.1IL1B, IL6
31mycoplasmal pneumonia10.1TLR1, TLR2, TNF
32congenital hypothyroidism10.1CD40LG, TLR2, TNF
33gastric leiomyoma10.1CD40LG, IL1B, IL6
34toxic optic neuropathy10.1IL1B, MMP9
35endogenous depression10.1CD40LG, TLR2, TNF
36basilar artery occlusion10.1CD40LG, HSPD1, TLR6
37dyslexia 510.1IL6, TNF
38dentin caries10.1CD40LG, TLR2, TNF
39tau syndrome10.1IL1B, TNF
40early yaws10.1CD40LG, IL1B, IL6
41cardioskeletal syndrome, kuwaiti type10.1TLR1, TLR2, TLR6
42conduct disorder10.1CD40LG, IL6, TNF
43childhood pleomorphic rhabdomyosarcoma10.1CD40LG, IL6, TNF
44fibrosis of extraocular muscles, congenital, 110.1TLR1, TLR2, TLR6
45hereditary alpha tryptasemia syndrome10.1CD40LG, IL6, TNF
46cicatricial lagophthalmos10.1CFHR1, IL6, TNF
47ectothrix infectious disease10.1TLR1, TLR2, TLR6
48dermatomycosis10.1C3, CD40LG, TNF
49plummer's disease10.1CD40LG, IL6, TNF
50multiple vertebral anomalies unusual facies10.1CFH, TNF

Graphical network of the top 20 diseases related to Lyme Disease:



Diseases related to lyme disease

Symptoms & Phenotypes for Lyme Disease

About this section

Symptoms:

 11 (show all 4)
  • fever
  • headache
  • fatigue
  • skin rash called erythema migrans

Human phenotypes related to Lyme Disease:

 54 64 (show all 24)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 uveitis64 54 Occasional (29-5%) HP:0000554
2 photophobia64 54 Occasional (29-5%) HP:0000613
3 behavioral abnormality54 Occasional (29-5%)
4 meningitis64 54 Frequent (79-30%) HP:0001287
5 muscle weakness64 54 Occasional (29-5%) HP:0001324
6 arthritis64 54 Frequent (79-30%) HP:0001369
7 joint swelling64 54 Frequent (79-30%) HP:0001386
8 atrioventricular block64 54 Occasional (29-5%) HP:0001678
9 fever64 54 Occasional (29-5%) HP:0001945
10 nausea and vomiting64 54 Occasional (29-5%) HP:0002017
11 headache64 54 Occasional (29-5%) HP:0002315
12 memory impairment64 54 Occasional (29-5%) HP:0002354
13 encephalitis64 54 Occasional (29-5%) HP:0002383
14 arthralgia64 54 Occasional (29-5%) HP:0002829
15 myalgia64 54 Occasional (29-5%) HP:0003326
16 paresthesia64 54 Occasional (29-5%) HP:0003401
17 dermal atrophy64 54 Occasional (29-5%) HP:0004334
18 cranial nerve paralysis64 54 Frequent (79-30%) HP:0006824
19 peripheral neuropathy54 Occasional (29-5%)
20 arrhythmia54 Occasional (29-5%)
21 fatigue64 54 Occasional (29-5%) HP:0012378
22 amaurosis fugax64 54 Occasional (29-5%) HP:0100576
23 insomnia64 54 Occasional (29-5%) HP:0100785
24 skin nodule64 54 Occasional (29-5%) HP:0200036

UMLS symptoms related to Lyme Disease:


fever, pruritus

MGI Mouse Phenotypes related to Lyme Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.4C3, CD40LG, CFH, IL1B, IL6, MMP9
2MP:00053678.4C3, CD40LG, CFH, IL17A, IL6, MMP9
3MP:00053798.2C3, CD40LG, CLDN11, IL17A, IL6, TLR2
4MP:00053897.6C3, CD40LG, CLDN11, HSPD1, IL6, MMP9
5MP:00036317.3C3, CD40LG, CFH, CLDN11, HSPD1, IL1B
6MP:00053907.0C3, CD40LG, IL17A, IL1B, IL6, MMP9
7MP:00107686.8C3, CD40LG, CFH, HSPD1, IL17A, IL1B
8MP:00053976.7C3, CD40LG, CFH, IL17A, IL1B, IL6
9MP:00053876.6C3, CD40LG, CFH, IL17A, IL1B, IL6

Drugs & Therapeutics for Lyme Disease

About this section

Drugs for Lyme Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 104)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CeftriaxoneapprovedPhase 4, Phase 3, Phase 1, Phase 211973384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
2
Doxycyclineapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2243564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
3
HydroxychloroquineapprovedPhase 4154118-42-33652
Synonyms:
(+-)-Hydroxychloroquine
(±)-hydroxychloroquine
118-42-3
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol
2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol
5-22-10-00280 (Beilstein Handbook Reference)
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline
7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
747-36-4 (sulfate (1:1) salt)
AC1L1GEW
BRN 0253894
C07043
C18H26ClN3O
CHEMBL1535
CID3652
D08050
DB01611
DivK1c_000942
EINECS 204-249-8
Gen-Hydroxychloroquine 200mg Tablets
HCQ
HMS502P04
Hidroxicloroquina
 
Hidroxicloroquina [INN-Spanish]
Hydroxychlorochin
Hydroxychloroguine
Hydroxychloroquine (INN)
Hydroxychloroquine Sulfate (1:1) Salt
Hydroxychloroquine [INN:BAN]
Hydroxychloroquinum
Hydroxychloroquinum [INN-Latin]
IDI1_000942
Idrossiclorochina
Idrossiclorochina [DCIT]
KBio1_000942
LS-66614
MolPort-003-847-792
NCGC00159483-02
NINDS_000942
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
PlaqueN/A
Polirreumin
Polirreumin (TN)
Quensyl
SPBio_001116
ST072188
Spectrum2_001238
Spectrum5_001697
UNII-4QWG6N8QKH
WIN 1258
hydroxychloroquine
4
Amoxicillinapproved, vet_approvedPhase 446526787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
5
Penicillin Vapproved, vet_approvedPhase 41787-08-16869
Synonyms:
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenoxyacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-3,3-dimethyl-7-oxo-6-{[(phenyloxy)acetyl]amino}-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
1098-87-9 (mono-hydrochloride salt)
132-98-9
132-98-9 (mono-potassium salt)
147-48-8 (mono-hydrochloride salt)
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carbonyl
2,2-dimethyl-6beta-[(phenoxyacetyl)amino]penam-3alpha-carboxylic acid
3,3-Dimethyl-7-oxo-6-((phenyloxyacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
3,3-dimethyl-6beta-[(phenoxyacetyl)amino]penam-2alpha-carboxylic acid (PIN)
4-27-00-05884 (Beilstein Handbook Reference)
6-Phenoxyacetamidopenicillanic acid
6-phenoxyacetamidopenicillanic acid
87-08-1
AB00514745
AC1L1NHG
AC1Q5QX3
AR-1H6492
Acipen V
Apocillin
Apopen
BRD-K43966364-237-02-2
BRN 0096259
BSPBio_002185
Beepen-VK
Beromycin
Beromycin, Penicillin
Berromycin, Penicillin
Betapen-VK
Bio-0630
C08126
C16H18N2O5S
CCRIS 752
CHEBI:27446
CHEBI:53706
CHEMBL615
CID6869
Calcipen
Compocillin V
Crystapen V
D05411
DB00417
DB08415
Distaquaine V
DivK1c_000779
EINECS 201-722-0
Eskacillian V
Eskacillin V
Fenacilin
Fenospen
Fenossimetilpenicillina
Fenossimetilpenicillina [DCIT]
Fenossimetilpenicillina [Dcit]
Fenoximetilpenicilina
Fenoximetilpenicilina [INN-Spanish]
Fenoxymethylpenicillin
Fenoxypen
HSDB 6314
IDI1_000779
KBio1_000779
KBio2_001487
KBio2_004055
KBio2_006623
KBio3_001685
KBioGR_000944
KBioSS_001487
 
LS-1861
MLS001304105
Meropenin
MolPort-002-515-462
NCGC00159342-02
NINDS_000779
Oracillin
Oratren
Ospen
P-Mega-Tablinen
PNV
PV
PVA
Pen-Oral
Pen-V
Pen-vee
Penapar-Vk
Penicillin Phenoxymethyl
Penicillin V
Penicillin V (USP)
Penicillin V Potassium
Penicillin V [USAN]
Penicillin phenoxymethyl
Penicillin, Phenoxymethyl
Penicillin-Vk
Phenocillin
Phenomycilline
Phenopenicillin
Phenoximethylpenicillinum
Phenoxomethylpenicillin
Phenoxymethyl Penicillin
Phenoxymethyl penicillin
Phenoxymethylenepenicillinic Acid
Phenoxymethylenepenicillinic acid
Phenoxymethylpenicillin
Phenoxymethylpenicillin (INN)
Phenoxymethylpenicillin Potassium
Phenoxymethylpenicilline
Phenoxymethylpenicilline [INN-French]
Phenoxymethylpenicillinic Acid
Phenoxymethylpenicillinic Acid Potassium Salt
Phenoxymethylpenicillinic acid potassium salt
Phenoxymethylpenicillinum
Phenoxymethylpenicillinum [INN-Latin]
Phénoxyméthylpénicilline
Robicillin
Rocilin
SMR000539431
SPBio_000389
Spectrum2_000495
Spectrum3_000543
Spectrum4_000472
Spectrum5_001409
Spectrum_001007
Stabicillin
UNII-Z61I075U2W
V-Cil
V-Cillin
V-Cillin (TN)
V-Cillin K
V-Cylina
V-Cyline
V-Tablopen
Vebecillin
Vegacillin
acipen-v
penicillin v
phenoxomethylpenicillanyl
phenoxomethylpenicillin
phenoxymethylpenicillanyl
phenoxymethylpenicillinic acid
6
Erythromycinapproved, vet_approvedPhase 499114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
érythromycine
7
AzithromycinapprovedPhase 4, Phase 1, Phase 234683905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
8
ClarithromycinapprovedPhase 428981103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
9
CefuroximeapprovedPhase 45655268-75-25361202, 5479529
Synonyms:
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime) carbamate (ester)
153012-39-6
3-[(carbamoyloxy)methyl]-7beta-[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-3,4-didehydrocepham-4-carboxylic acid
55268-75-2
56238-63-2
AC-15028
AC-4539
AC1NUIFB
AC1Q41FS
Anaptivan
BIDD:GT0619
BPBio1_001033
BRD-K02733959-236-02-8
BRN 5783190
BSPBio_000939
Biociclin
Biofuroksym
Bioxima
C06894
C08108
C16H15N4O8S.Na
C16H16N4O8S
C4417_FLUKA
C4417_SIGMA
CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER
CEFUROXIME SODIUM
CHEBI:3515
CHEMBL1436
CID5479529
CID6523269
CPD0-2069
CXM
Cefofix
Cefumax
Cefurex
Cefuril
Cefuroxim
Cefuroxim AJ
Cefuroxim Fresenius
Cefuroxim Genericsn
Cefuroxim Hexal
Cefuroxim Lilly
Cefuroxim MN
Cefuroxim Norcox
Cefuroxim Norcox [inj.]
Cefuroxim curasan
Cefuroxima Fabra
Cefuroxima Richet
Cefuroxime
Cefuroxime (TN)
 
Cefuroxime (USAN/INN)
Cefuroxime [USAN:BAN:INN]
Cefuroxime [USAN:INN:BAN]
Cefuroxime for Injection and Dextrose for Injection in Duplex Container
Cefuroxime sodium (JP15/USP)
Cefuroxime sodium [USAN:BAN:JAN]
Cefuroxime sodium salt
Cefuroximine
Cefuroximo
Cefuroximo [INN-Spanish]
Cefuroximum
Cefuroximum [INN-Latin]
Cephuroxime
Cetroxil
Cetroxil [inj.]
Colifossim
Curocef
Curoxim
Curoxima
Curoxime
D00262
D00915
EINECS 259-560-1
EINECS 260-073-1
Froxal
Froxal [inj.]
Furoxil
KEFUROX IN PLASTIC CONTAINER
KS-1040
Kesint
Ketocef
LS-149936
LS-2226
Lifurox
Medoxim
MolPort-002-885-814
MolPort-005-938-003
Prestwick3_000720
Sharox
Sharox [inj.]
Sodium (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), carbamate (ester)
Sodium (6R-(6alpha,7beta(Z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium cefuroxime
Spectrazolr
UNII-O1R9FJ93ED
UNII-R8A7M9MY61
Ultroxim
ZINACEF IN PLASTIC CONTAINER
Zinacef
Zinacef (TN)
Zinacef Danmark
Zinacef danmark
Zinnat [inj.]
cefuroxime
cefuroxime na
cefuroximesodium
10
Methylprednisoloneapproved, vet_approvedPhase 4119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
11
Prednisoloneapproved, vet_approvedPhase 4119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
12Antiparasitic AgentsPhase 4, Phase 3, Phase 22199
13Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
14Antiprotozoal AgentsPhase 4, Phase 3, Phase 22051
15Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 111226
16AntimalarialsPhase 4, Phase 3, Phase 21246
17Antitubercular AgentsPhase 4, Phase 21343
18Erythromycin stearatePhase 499
19Erythromycin EthylsuccinatePhase 499
20Erythromycin EstolatePhase 499
21Cytochrome P-450 Enzyme InhibitorsPhase 43917
22Cytochrome P-450 CYP3A InhibitorsPhase 41715
23cefuroxime axetilPhase 456
24Antirheumatic AgentsPhase 410956
25Antibiotics, AntitubercularPhase 4, Phase 3, Phase 2, Phase 17180
26penicillinsPhase 4114
27Peripheral Nervous System AgentsPhase 423689
28Gastrointestinal AgentsPhase 4, Phase 18402
29Autonomic AgentsPhase 410150
30AntiemeticsPhase 44022
31Neuroprotective AgentsPhase 41716
32Protective AgentsPhase 47443
33Prednisolone acetatePhase 41193
34Prednisolone hemisuccinatePhase 41193
35Prednisolone phosphatePhase 41193
36Anti-Inflammatory AgentsPhase 410729
37glucocorticoidsPhase 45103
38Antineoplastic Agents, HormonalPhase 45592
39Hormone AntagonistsPhase 413180
40HormonesPhase 414415
41Methylprednisolone acetatePhase 41193
42Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 413168
43Methylprednisolone HemisuccinatePhase 41193
44
Minocyclineapproved, investigationalPhase 323110118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline HCl
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
NCGC00178854-01
NSC 141993
NSC141993
Novo-Minocycline
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
45
OsimertinibapprovedPhase 3591421373-65-071496458
Synonyms:
Mereletinib
 
N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide
Tagrisso
mereletinib
46
Permethrinapproved, investigationalPhase 33452645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
 
DB04930
Elimite Cream
FMC 35171
LS-58636
LS-58640
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
TL8003462
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
47VaccinesPhase 3, Phase 1, Phase 26611
48Protein Kinase InhibitorsPhase 33689
49MitogensPhase 31617
50PENTAPhase 3109

Interventional clinical trials:

(show top 50)    (show all 62)
idNameStatusNCT IDPhase
1Study of Lyme NeuroborreliosisUnknown statusNCT01635530Phase 4
2Persistent Lyme Empiric Antibiotic Study EuropeCompletedNCT01207739Phase 4
3Comparing 3 Antibiotic Regimes for Erythema Migrans in General PracticeCompletedNCT01368341Phase 4
4Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological OutcomeCompletedNCT01518192Phase 4
5Aizthromycin or Clarithromycin in H-pylori Eradication RegimenCompletedNCT01667692Phase 4
6The Study to Treat Superficial Femoral Artery Occlusions.CompletedNCT00232843Phase 4
7Injection Versus Splinting in Carpal Tunnel SyndromeActive, not recruitingNCT02038452Phase 4
8Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyUnknown statusNCT00203697Phase 3
9A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme DiseaseCompletedNCT00001101Phase 3
10A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme DiseaseCompletedNCT00000938Phase 3
11Study and Treatment of Post Lyme Disease (STOP-LD)CompletedNCT00000937Phase 3
12Lyme Disease Prevention ProgramCompletedNCT00000432Phase 3
13Post Exposure Treatment With Doxycycline for the Prevention of Relapsing FeverCompletedNCT00237016Phase 2, Phase 3
14Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme NeuroborreliosisCompletedNCT00138801Phase 3
15Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
16Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLCRecruitingNCT02474355Phase 3
17Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryActive, not recruitingNCT02138916Phase 3
18Six Versus Two Weeks Treatment With Doxycycline in Lyme NeuroborreliosisEnrolling by invitationNCT02553473Phase 3
19Passive Prophylaxis of Lyme Disease Using Permethrin Treated ClothesTerminatedNCT00958139Phase 3
20A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory PsychosisUnknown statusNCT00591318Phase 1, Phase 2
21Phase 1/2 Lyme Vaccine StudyCompletedNCT01504347Phase 1, Phase 2
22Safety, Skin and Plasma Concentration of Azithromycin Dermal FormulationCompletedNCT01243008Phase 1, Phase 2
23Brain Imaging and Retreatment Study of Persistent Lyme DiseaseCompletedNCT00037479Phase 2
24Antibiotic Treatment Trial for the PANDAS/PANS PhenotypeCompletedNCT01617083Phase 2
25Efficacy of 1072nm Infrared Stimulation on Executive Functioning in DementiaCompletedNCT01059877Phase 1, Phase 2
26Xenodiagnosis After Antibiotic Treatment for Lyme DiseaseRecruitingNCT02446626Phase 1, Phase 2
27A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic ChildrenCompletedNCT00670891Phase 1
28Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme BorreliosisRecruitingNCT03010228Phase 1
29Lyme Borreliosis and Early Cutaneous DiagnosticUnknown statusNCT02414789
30Human Anaplasmosis in Eastern FranceUnknown statusNCT01013636
31Doxycycline and Ceftriaxone in Suspected Early Lyme NeuroborreliosisUnknown statusNCT00942006
32Meditation and Stretching for Post Treatment Lyme Disease SyndromeUnknown statusNCT02344537
33300 Antibody Diagnostic Test KitUnknown statusNCT01646411
34Doxycycline in Therapy of Erythema MigransCompletedNCT01475708
35Duration of Antibiotic Treatment of Erythema MigransCompletedNCT00910715
36The Phenomenon of "Chronic Lyme"; an Observational StudyCompletedNCT01151150
37Microbiologic Findings of Acute Facial Palsy in ChildrenCompletedNCT01537952
38Culture Media for Borrelia Burgdorferi Sensu LatoCompletedNCT02145754
39Searching for Persistence of Infection in Lyme DiseaseCompletedNCT01143558Early Phase 1
40Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830
41Study of Anti-HIV Therapy IntensificationCompletedNCT00034086
42Borrelia Species in Cutaneous Lyme BorreliosisRecruitingNCT00576082
43Study on Early Lyme NeuroborreliosisRecruitingNCT00910533
44Tick-borne Encephalitis and Positive Borrelial AntibodiesRecruitingNCT02463942
45Cytokines and Chemokines in Erythema MigransRecruitingNCT02147249
46Antibiotic Treatment of Multiple Erythema MigransRecruitingNCT01163994
47Laboratory Characteristics in Chronic Atrophic AcrodermatitisRecruitingNCT02147262
48Evaluation of Lyme Disease: Clinical, Microbiological and Immunological CharacteristicsRecruitingNCT00001539
49Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruitingNCT00028080
50A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme DiseaseRecruitingNCT02741609

Search NIH Clinical Center for Lyme Disease


Cochrane evidence based reviews: lyme neuroborreliosis

Genetic Tests for Lyme Disease

About this section

Anatomical Context for Lyme Disease

About this section

MalaCards organs/tissues related to Lyme Disease:

36
Heart, Testes, Skin, Eye, Brain, T cells, Endothelial

Publications for Lyme Disease

About this section

Articles related to Lyme Disease:

(show top 50)    (show all 785)
idTitleAuthorsYear
1
A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease. (27914746)
2017
2
Tick bite and Lyme disease-related emergency department encounters in New Hampshire, 2010-2014. (28432738)
2017
3
Relative Risk for Ehrlichiosis and Lyme Disease in an Area Where Vectors for Both Are Sympatric, New Jersey, USA. (28518034)
2017
4
Lyme Disease: A Case Report with Typical and Atypical Lesions. (28405553)
2017
5
Isolation of the Lyme Disease Spirochete Borrelia mayonii From Naturally Infected Rodents in Minnesota. (28444198)
2017
6
Use of a tick-borne disease manual increases accuracy of tick identification among primary care providers in Lyme disease endemic areas. (27916581)
2017
7
A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Borrelia burgdorferi, causative agent of Lyme disease, in domestic dogs within the contiguous United States. (28472096)
2017
8
Temperature-dependent sRNA transcriptome of the Lyme disease spirochete. (28056764)
2017
9
Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete. (28484210)
2017
10
Dealing with Lyme Disease Treatment. (28431674)
2017
11
Comparison of Vector Efficiency of Ixodes scapularis (Acari: Ixodidae) From the Northeast and Upper Midwest of the United States for the Lyme Disease Spirochete Borrelia mayonii. (28082653)
2017
12
Lyme disease risk in southern California: abiotic and environmental drivers of Ixodes pacificus (Acari: Ixodidae) density and infection prevalence with Borrelia burgdorferi. (28057067)
2017
13
Gene Sequencing and Cases of Chronic Lyme Disease-Reply. (28460104)
2017
14
Environmental Factors Affecting Survival of Immature Ixodes scapularis and Implications for Geographical Distribution of Lyme Disease: The Climate/Behavior Hypothesis. (28076359)
2017
15
Gene Sequencing and Cases of Chronic Lyme Disease. (28460095)
2017
16
A Case of Early Disseminated Neurological Lyme Disease Followed by Atypical Cutaneous Manifestations. (28512589)
2017
17
Geographic Expansion of Lyme Disease in Michigan, 2000-2014. (28480261)
2017
18
Application of Bayesian decision-making to laboratory testing for Lyme disease and comparison with testing for HIV. (28435311)
2017
19
A systematic review and meta-analysis for the adverse effects, immunogenicity and efficacy of Lyme disease vaccines: Guiding novel vaccine development. (28425901)
2017
20
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. (28440258)
2017
21
TH17 Cytokine Responses in Lyme Disease Correlate with Borreliaburgdorferi Antibodies During Early Infection in Patients with Erythema Migrans and with Autoantibodies Late in the Illness in Patients with Antibiotic-Refractory Lyme Arthritis. (28077518)
2017
22
Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development. (28479174)
2017
23
Borrelia burgdorferi-specific IgA in Lyme Disease. (28457619)
2017
24
Evaluation of the SELECT Tick Control System (TCS), a Host-Targeted Bait Box, to Reduce Exposure to Ixodes scapularis (Acari: Ixodidae) in a Lyme Disease Endemic Area of New Jersey. (28399280)
2017
25
Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015. (28532428)
2017
26
Succinyl-I^-cyclodextrin modified gold biochip improved seroimmunological detection sensitivity for Lyme disease. (28010742)
2017
27
Pleomorphism and Viability of the Lyme Disease Pathogen Borrelia burgdorferi Exposed to Physiological Stress Conditions: A Correlative Cryo-Fluorescence and Cryo-Scanning Electron Microscopy Study. (28443079)
2017
28
Lyme disease ecology in a changing world: consensus, uncertainty and critical gaps for improving control. (28438910)
2017
29
Lyme Disease Serology. (27115380)
2016
30
Lyme Disease. (27136224)
2016
31
The latest evidence on Lyme disease. (27498520)
2016
32
Not All Erythema Migrans Lesions are Lyme Disease. (27612442)
2016
33
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (27602675)
2016
34
Lyme disease. (27650153)
2016
35
Yamamoto New Scalp Acupuncture, Applied Kinesiology, and Breathing Exercises for Facial Paralysis in a Young Boy Caused by Lyme Disease-A Case Report. (27102135)
2016
36
False Positive Lyme Disease IgM Immunoblots in Children. (27157898)
2016
37
Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures. (27025825)
2016
38
Palisaded neutrophilic and granulomatous dermatitis - cutaneous manifestation of Lyme disease or connected with CTD? Case report. (27294654)
2016
39
A Case of Lyme Disease Accompanied by Uveitis and White Dot Syndrome. (28058168)
2016
40
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. (27028918)
2016
41
Expression of C-Reactive Protein and Serum Amyloid A in Early to Late Manifestations of Lyme Disease. (27585799)
2016
42
Longer-Term Therapy for Symptoms Attributed to Lyme Disease. (27602673)
2016
43
Lyme Disease in West Virginia: An Assessment of Distribution and Clinicians' Knowledge of Disease and Surveillance. (27491103)
2016
44
Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. (27598389)
2016
45
Susceptibility, likelihood to be diagnosed, worry and fear for contracting Lyme disease. (27026135)
2016
46
Lyme disease caused by Borrelia burgdorferi with two homeologous 16S rRNA genes: a case report. (27186082)
2016
47
When in Doubt, Examine the Patient: Commentary on an article by Keith D. Baldwin, MD, MSPT, MPH, et al.: "Predictive Factors for Differentiating Between Septic Arthritis and Lyme Disease of the Knee in Children". (27147695)
2016
48
Evidence of rapid changes in Lyme disease awareness in Canada. (27665265)
2016
49
Human Granulocytic Anaplasmosis and Lyme Disease. (27380349)
2016
50
The Lyme disease pathogen Borrelia burgdorferi infects murine bone and induces trabecular bone loss. (27956598)
2016

Variations for Lyme Disease

About this section

Expression for genes affiliated with Lyme Disease

About this section
Search GEO for disease gene expression data for Lyme Disease.

Pathways for genes affiliated with Lyme Disease

About this section

Pathways related to Lyme Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 54)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL1B, IL6
29.6IL1B, TNF
39.4CD40LG, IL1B, TNF
49.3IL1B, TLR2, TNF
69.3IL1B, IL6, TNF
79.3IL1B, IL6, TNF
89.3IL1B, IL6, TNF
99.3IL1B, IL6, TNF
109.3IL1B, IL6, TNF
119.3IL1B, IL6, TNF
129.3IL1B, IL6, TNF
139.3IL1B, IL6, TNF
149.3IL1B, IL6, TNF
159.2IL6, MMP9, TNF
169.1CD40LG, IL6, TLR2, TNF
178.9IL1B, IL6, TLR2, TNF
188.9IL1B, MMP9, TLR1, TLR2
198.9C3, IL1B, IL6, TNF
208.9C3, TLR1, TLR2, TLR6
21
Show member pathways
8.8IL1B, TLR1, TLR2, TLR6
228.8IL17A, IL1B, TNF
238.7HSPD1, IL1B, IL6, TNF
248.7IL1B, IL6, MMP9, TNF
258.7IL1B, IL6, MMP9, TNF
268.7IL1B, IL6, MMP9, TNF
278.7CD40LG, IL1B, IL6, TLR2, TNF
28
Show member pathways
8.7C3, CD40LG, IL1B, TLR2, TNF
29
Show member pathways
8.6C3, IL1B, IL6, TLR2, TNF
30
Show member pathways
8.5CD40LG, IL1B, IL6, MMP9, TNF
31
Show member pathways
8.4IL6, TLR1, TLR2, TLR6, TNF
32
Show member pathways
8.4IL17A, IL1B, IL6, TNF
33
Show member pathways
8.4IL17A, IL1B, IL6, TNF
348.4IL17A, IL1B, IL6, TNF
35
Show member pathways
8.2CD40LG, IL17A, IL1B, IL6, TNF
368.2CD40LG, IL17A, IL1B, IL6, TNF
37
Show member pathways
8.1CD40LG, IL1B, TLR1, TLR2, TLR6, TNF
38
Show member pathways
8.1IL17A, IL1B, IL6, TLR2, TNF
398.1IL17A, IL1B, IL6, TLR2, TNF
408.0C3, HSPD1, IL1B, IL6, TLR2, TNF
41
Show member pathways
8.0IL1B, IL6, TLR1, TLR2, TLR6, TNF
42
Show member pathways
8.0IL1B, IL6, TLR1, TLR2, TLR6, TNF
437.9IL6, MMP9, TLR1, TLR2, TLR6, TNF
447.9IL17A, IL1B, IL6, MMP9, TNF
45
Show member pathways
7.8CD40LG, IL1B, IL6, TLR1, TLR2, TLR6
46
Show member pathways
7.7IL17A, IL1B, IL6, TLR1, TLR2, TLR6
47
Show member pathways
7.6IL17A, IL1B, IL6, MMP9, TLR2, TNF
487.3CD40LG, IL17A, IL1B, TLR1, TLR2, TLR6
49
Show member pathways
7.3C3, CD40LG, HSPD1, IL17A, IL1B, IL6
50
Show member pathways
7.2IL17A, IL1B, IL6, TLR1, TLR2, TLR6

GO Terms for genes affiliated with Lyme Disease

About this section

Cellular components related to Lyme Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Toll-like receptor 1-Toll-like receptor 2 protein complexGO:00353549.9TLR1, TLR2
2external side of plasma membraneGO:00098979.4CD40LG, IL17A, IL6, TNF
3phagocytic vesicle membraneGO:00306709.2TLR1, TLR2, TLR6
4membrane raftGO:00451218.8HSPD1, TLR1, TLR2, TLR6, TNF
5extracellular regionGO:00055767.5C3, CD40LG, CFH, CFHR1, IL17A, IL1B
6extracellular spaceGO:00056156.9C3, CD40LG, CFH, CFHR1, HSPD1, IL17A

Biological processes related to Lyme Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idNameGO IDScoreTop Affiliating Genes
1cellular response to triacyl bacterial lipopeptideGO:007172710.7TLR1, TLR2
2detection of triacyl bacterial lipopeptideGO:004249510.7TLR1, TLR2
3complement activation, alternative pathwayGO:000695710.6C3, CFH
4epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.5IL6, TNF
5negative regulation of lipid storageGO:001088810.4IL6, TNF
6regulation of immunoglobulin secretionGO:005102310.4CD40LG, TNF
7complement activationGO:000695610.4C3, CFH, CFHR1
8negative regulation of lipid catabolic processGO:005099510.4IL1B, TNF
9positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IL1B, TNF
10positive regulation of chemokine biosynthetic processGO:004508010.3IL1B, TNF
11positive regulation of fever generationGO:003162210.3IL1B, TNF
12positive regulation of heterotypic cell-cell adhesionGO:003411610.3IL1B, TNF
13positive regulation of membrane protein ectodomain proteolysisGO:005104410.3IL1B, TNF
14cellular response to diacyl bacterial lipopeptideGO:007172610.3TLR2, TLR6
15detection of diacyl bacterial lipopeptideGO:004249610.3TLR2, TLR6
16microglial cell activationGO:000177410.3TLR2, TLR6
17nitric oxide metabolic processGO:004620910.3TLR2, TLR6
18regulation of establishment of endothelial barrierGO:190314010.2IL1B, TNF
19regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.2IL1B, TNF
20regulation of complement activationGO:003044910.2C3, CFH, CFHR1
21response to bacterial lipoproteinGO:003249310.2TLR2, TLR6
22positive regulation of vascular smooth muscle cell proliferationGO:190470710.2MMP9, TNF
23positive regulation of T cell proliferationGO:004210210.1CD40LG, IL1B, IL6
24defense response to Gram-positive bacteriumGO:005083010.1IL6, TLR2, TNF
25positive regulation of interleukin-10 productionGO:003273310.1CD40LG, HSPD1, TLR2
26positive regulation of interleukin-12 productionGO:003273510.1CD40LG, HSPD1, TLR2
27positive regulation of chemokine productionGO:003272210.1IL6, TLR2, TNF
28sequestering of triglycerideGO:003073010.1IL1B, TNF
29lipopolysaccharide-mediated signaling pathwayGO:003166310.0IL1B, TLR2, TNF
30cell activationGO:000177510.0TLR1, TLR2, TLR6
31response to coldGO:000940910.0HSPD1, IL6, YBX3
32positive regulation of interleukin-8 productionGO:003275710.0IL1B, TLR2, TNF
33positive regulation of NF-kappaB import into nucleusGO:004234610.0IL1B, TLR2, TNF
34positive regulation of nitric oxide biosynthetic processGO:004542910.0IL1B, IL6, TNF
35toll-like receptor TLR1:TLR2 signaling pathwayGO:00381239.9TLR1, TLR2
36positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.9IL1B, IL6, TNF
37positive regulation of phagocytosisGO:00507669.9C3, IL1B, TNF
38regulation of cytokine secretionGO:00507079.9TLR1, TLR2, TLR6
39positive regulation of interleukin-6 biosynthetic processGO:00454109.9IL1B, TLR1, TLR6
40positive regulation of interferon-gamma productionGO:00327299.8HSPD1, IL1B, TNF
41response to glucocorticoidGO:00513849.8HSPD1, IL6, TNF
42positive regulation of gene expressionGO:00106289.7IL1B, IL6, TLR2, TNF
43toll-like receptor TLR6:TLR2 signaling pathwayGO:00381249.5TLR2, TLR6
44MyD88-dependent toll-like receptor signaling pathwayGO:00027559.5HSPD1, TLR1, TLR2, TLR6
45positive regulation of interleukin-6 secretionGO:20007789.4HSPD1, IL17A, IL1B
46toll-like receptor signaling pathwayGO:00022249.4TLR1, TLR2, TLR6
47positive regulation of NF-kappaB transcription factor activityGO:00510929.4CD40LG, IL1B, IL6, TLR2, TNF
48positive regulation of protein phosphorylationGO:00019349.4C3, IL1B, MMP9, TNF
49innate immune responseGO:00450879.4C3, CFH, TLR1, TLR2, TLR6
50positive regulation of apoptotic processGO:00430659.4HSPD1, IL6, MMP9, TNF

Molecular functions related to Lyme Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Toll-like receptor 2 bindingGO:00356639.6TLR1, TLR6
2lipopeptide bindingGO:00717239.3TLR1, TLR2, TLR6
3cytokine activityGO:00051258.5CD40LG, IL17A, IL1B, IL6, TNF

Sources for Lyme Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet